Walsh B T, Stewart J W, Roose S P, Gladis M, Glassman A H
J Psychiatr Res. 1985;19(2-3):485-9. doi: 10.1016/0022-3956(85)90058-5.
Thirty normal weight women with bulimia completed a double-blind, placebo-controlled trial of phenelzine sulfate. The results demonstrate a significant therapeutic advantage for phenelzine over placebo. Preliminary data suggest that phenelzine may be of benefit even to non-depressed patients with bulimia.